ArticleResearch square2024

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia.

Adnan Akif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.